Skip to main content

Table 1 Anthropometric, clinical, and laboratory data in the obese and control groups

From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children

 Obese group (mean ± SD)Control group (mean ± SD)p value
Height (SDS)0.467 ± 1.10− 0.765 ± 0.5770.042
Weight (SDS)3.16 ± 1.52− 0.0319 ± 0.5940.000**
BMI (kg/m2)29.87 ± 3.3518.22 ± 1.870.000**
BMI (SDS)3.123 ± 0.607− 0.776 ± 0.7890.000**
Waist circumference (cm)88.38 ± 8.2857.33 ± 4.760.000**
Hip circumference (cm)94.08 ± 9.8768.86 ± 7.330.000**
W/H ratio0.938 ± 0.0530.830 ± 0.0470.000**
Biceps skin fold (SDS)1.9 ± 1.721.15 ± 1.20.000**
Triceps skin fold (SDS)2 ± 1.770.80 ± 1.080.000**
Subscapular skin fold (SDS)3 ± 4.960.9 1 ± 1.060.000**
Systolic Bp (mmHg)115.28 ± 9.06101.40 ± 6.380.000**
Diastolic Bp (mmHg)77.79 ± 11.5663.79 ± 5.970.000**
Total cholesterol (mg/dl)168.40 ± 28.44144.17 ± 25.970. 000
Triglycerides (mg/dl)100.51 ± 29.6757.60 ± 15.020.000
HDL-c (mg/dl)41.23 ± 10.8743.191 ± 11.0370.412
LDL-c (mg/dl)103.05 ± 32.3989.74 ± 20.740.027
FBS (mg/dl)94.37 ± 9.5187.69 ± 9.940.001
Insulin (μIU/ml)17.75 ± 8.0677.78 ± 2.580.000
HOMA-IR4.14 ± 1.941.67 ± 0.6090.000
PAI-1 (ng/dl)47.98 ± 17.4228.00 ± 11.350.000
  1. W/H waist/hip ratio, BMI body mass index, SDS standard deviation score, Bp blood pressure
  2. **p value highly significant < 0.01